Stock News

EPS for TETRA Technologies, Inc. (TTI) Expected At $-0.08; J Goldman & Company LP Has Lowered Rigel Pharmaceuticals (Call) (RIGL) Position

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Logo

J Goldman & Company Lp decreased Rigel Pharmaceuticals Inc (Call) (RIGL) stake by 97.87% reported in 2017Q4 SEC filing. J Goldman & Company Lp sold 915,100 shares as Rigel Pharmaceuticals Inc (Call) (RIGL)’s stock rose 8.02%. The J Goldman & Company Lp holds 19,900 shares with $77,000 value, down from 935,000 last quarter. Rigel Pharmaceuticals Inc (Call) now has $565.90 million valuation. The stock decreased 5.42% or $0.22 during the last trading session, reaching $3.84. About 15.02 million shares traded or 452.82% up from the average. Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has risen 9.91% since April 21, 2017 and is uptrending. It has underperformed by 1.64% the S&P500.

Analysts expect TETRA Technologies, Inc. (NYSE:TTI) to report $-0.08 EPS on May, 9.They anticipate $0.02 EPS change or 20.00% from last quarter’s $-0.1 EPS. After having $-0.04 EPS previously, TETRA Technologies, Inc.’s analysts see 100.00% EPS growth. It closed at $3.67 lastly. It is down 1.86% since April 21, 2017 and is downtrending. It has underperformed by 13.41% the S&P500.

Investors sentiment increased to 1.32 in 2017 Q4. Its up 0.68, from 0.64 in 2017Q3. It increased, as 17 investors sold TETRA Technologies, Inc. shares while 36 reduced holdings. 32 funds opened positions while 38 raised stakes. 96.68 million shares or 1.19% less from 97.84 million shares in 2017Q3 were reported. 46,300 are held by Hutchin Hill L P. State Of Tennessee Treasury Department holds 91,664 shares. Royal Comml Bank Of Canada has 0% invested in TETRA Technologies, Inc. (NYSE:TTI) for 125,350 shares. Engineers Gate Manager Ltd Partnership reported 127,717 shares or 0.04% of all its holdings. Proshare Advsrs Limited Liability invested in 20,523 shares or 0% of the stock. Moreover, Ls Limited Liability has 0% invested in TETRA Technologies, Inc. (NYSE:TTI) for 3,355 shares. Alliancebernstein Limited Partnership invested 0% in TETRA Technologies, Inc. (NYSE:TTI). Rhumbline Advisers holds 0% or 270,068 shares. Moreover, Assetmark Incorporated has 0% invested in TETRA Technologies, Inc. (NYSE:TTI). 367,124 were accumulated by California Pub Employees Retirement Sys. State Street Corporation has 3.28 million shares for 0% of their portfolio. First Quadrant Limited Partnership Ca stated it has 20,333 shares or 0% of all its holdings. Renaissance Ltd Liability Co invested in 788,300 shares. Eqis Capital Mngmt Inc holds 0% in TETRA Technologies, Inc. (NYSE:TTI) or 16,008 shares. Ameritas Investment holds 9,415 shares.

TETRA Technologies, Inc., together with its subsidiaries, operates as a diversified gas and oil services company. The company has market cap of $463.19 million. It operates through four divisions: Fluids, Production Testing, Compression, and Offshore. It currently has negative earnings. The Fluids division makes and markets clear brine fluids, additives, and associated services and products to the gas and oil industry for use in well drilling, completion, and workover activities in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa.

Since March 21, 2018, it had 1 insider purchase, and 0 selling transactions for $29,602 activity. Evans Elisabeth K had bought 7,600 shares worth $29,602 on Wednesday, March 21.

Among 15 analysts covering Tetra Technologies (NYSE:TTI), 10 have Buy rating, 0 Sell and 5 Hold. Therefore 67% are positive. Tetra Technologies had 42 analyst reports since August 10, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Thursday, January 11 by Scotia Capital. The stock of TETRA Technologies, Inc. (NYSE:TTI) earned “Hold” rating by RBC Capital Markets on Thursday, November 9. The rating was maintained by Credit Suisse with “Outperform” on Thursday, March 1. The firm earned “Neutral” rating on Tuesday, September 12 by JP Morgan. Wunderlich maintained TETRA Technologies, Inc. (NYSE:TTI) on Tuesday, May 10 with “Buy” rating. RBC Capital Markets maintained TETRA Technologies, Inc. (NYSE:TTI) on Friday, October 6 with “Hold” rating. Credit Suisse reinitiated TETRA Technologies, Inc. (NYSE:TTI) on Monday, July 18 with “Outperform” rating. The rating was downgraded by Credit Suisse to “Neutral” on Tuesday, November 8. The stock of TETRA Technologies, Inc. (NYSE:TTI) has “Buy” rating given on Thursday, December 22 by Bank of America. RBC Capital Markets maintained TETRA Technologies, Inc. (NYSE:TTI) on Tuesday, May 10 with “Outperform” rating.

J Goldman & Company Lp increased Extended Stay Amer Inc (Call) (NYSE:STAY) stake by 192,200 shares to 205,000 valued at $3.90M in 2017Q4. It also upped Boingo Wireless Inc (NASDAQ:WIFI) stake by 198,171 shares and now owns 308,171 shares. Nxp Semiconductors N V (Call) (NASDAQ:NXPI) was raised too.

Among 6 analysts covering Rigel Pharmaceuticals (NASDAQ:RIGL), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Rigel Pharmaceuticals had 26 analyst reports since August 8, 2015 according to SRatingsIntel. Piper Jaffray maintained Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) rating on Tuesday, August 30. Piper Jaffray has “Overweight” rating and $11 target. The firm has “Buy” rating by H.C. Wainwright given on Friday, January 19. BMO Capital Markets maintained Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) on Wednesday, April 18 with “Outperform” rating. The firm has “Buy” rating by BMO Capital Markets given on Wednesday, June 7. BMO Capital Markets maintained it with “Buy” rating and $500 target in Monday, June 19 report. Cantor Fitzgerald maintained it with “Buy” rating and $7.0 target in Tuesday, March 6 report. The rating was maintained by H.C. Wainwright on Monday, December 11 with “Buy”. The firm earned “Buy” rating on Tuesday, November 7 by BMO Capital Markets. As per Monday, October 2, the company rating was maintained by BMO Capital Markets. The rating was maintained by Jefferies with “Buy” on Wednesday, April 4.

Analysts await Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) to report earnings on May, 1. They expect $-0.17 earnings per share, down 30.77% or $0.04 from last year’s $-0.13 per share. After $-0.18 actual earnings per share reported by Rigel Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -5.56% EPS growth.

TETRA Technologies, Inc. (NYSE:TTI) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *